Biogen Idec, Inc. (Massachusetts) (BIIB) Poaches Renowned Neurologist From Novartis AG (NVS) To Lead ALS Innovation Hub
South San Francisco's Calithera Biosciences, Inc. Seeks $80 Million In IPO
Drug Giants Merck & Co., Inc. (MRK) And Pfizer Inc. (PFE) Forge Cancer Pact
Massachusetts' Civitas Therapeutics Locks In $55 Million
Disappointment Looms As Roche (RHHBY) Drops Plans To Bid For The Rest Of Chugai Pharmaceutical Co., Ltd. (Japan)
SoCal's Kite Pharma, Inc. (KITE) Shares Fly High On Non-Hodgkin's Lymphoma Drug Study Results
Novozymes A/S (NVZMY)' $36 Million, 100-Job Planned R&D Facility Has A Location Complication
No Biotech Copycat Drug Lift Off Before 2017: Novartis AG (NVS) CEO Predicts
VIVUS, Inc. (VVUS) Snags A Group Of Topiramate Patents From Johnson & Johnson (JNJ)
Charles Walker Appointed Imugene Limited (IMU.AX) CEO
Nordic Nanovector: The Board Appoints Mr. Luigi Costa As New CEO
StemCutis Attracts Stem Cell Entrepreneur For Top Post
Roche (RHHBY) Pays $8.3 Billion For Bay Area's InterMune, Inc. (ITMN), Pledges To Keep Employees
Is Amazon.com (AMZN) About To Bust Into Healthcare? FDA Reveals Meeting With The Online Retailer
Regado Biosciences, Inc. (RGDO) Permanently Halts Enrollment In Lead Drug Trial
Tiny Biotech Advaxis, Inc. Inks Another Pact With Merck & Co., Inc. (MRK) To Test Immune Therapies Against Prostate Cancer
Redwood City Startup, Aldea Pharmaceuticals, Reels In $24 Million
Phosphagenics Limited (POH.AX)'s Ex-Chief Guilty Of Theft
See All News >
//-->